Lung Cancer Screening. Eric S. Papierniak, DO NF/SG VHA UF Health
|
|
- Willis Robinson
- 5 years ago
- Views:
Transcription
1 Lung Cancer Screening Eric S. Papierniak, DO NF/SG VHA UF Health
2 Overview Background Supporting evidence Guidelines Practical considerations Patient selection What to do with abnormal results Billing/coding
3 Background Lung cancer is the third most common cancer in the US, behind breast and prostate
4
5 Background Lung cancer is the third most common cancer in the US, behind breast and prostate It is the leading cause of cancerrelated death, however
6
7 Background Lung cancer is the third most common cancer in the US, behind breast and prostate It is the leading cause of cancerrelated death, however Responsible for more deaths than the next 3 deadliest cancers combined
8
9 Background This trend holds for both men and women
10
11 Background Early detection could result in a substantial survival benefit as most patients are diagnosed with metastatic disease
12
13 Does screening work? Screening for lung cancer by plain chest radiographs (CXR) has been shown to be ineffective in multiple RCTs dating back to the 1970s but interest (and use) continued for many years
14 Does screening work? Starting in 2001, a number of trials were published evaluating screening with low dose CT (LDCT) Screening via any method was not recommended by any major society/group until recently
15 National Lung Screening Trial (NLST) The NLST randomized 53,454 highrisk patients to either plain CXR or LDCT Imaging was performed at enrollment and annually for 2 years (3 total) N Engl J Med 2011; 365:
16 NLST 1060 patients in LDCT group and 941 patients in CXR group were diagnosed with lung cancer Most of the cancers in the LDCT group were found via screening Most cancers in the CXR group were not N Engl J Med 2011; 365:
17 Cumulative Numbers of Lung Cancers and of Deaths from Lung Cancer. The National Lung Screening Trial Research Team. N Engl J Med 2011;365:
18 NLST More cancers were found in the LDCT group but there were fewer deaths N Engl J Med 2011; 365:
19 NLST 354 deaths in LDCT group 442 in CXR group 20% relative risk reduction Number needed to screen: 320 N Engl J Med 2011; 365:
20 Review of Guidelines USPSTF: Ann Intern Med. 2014;160: ACCP: Chest 2018; 153(4):
21 Who to screen? Age (80) Smoking history of 30 pack-years or more Still smoking or quit less than 15 years ago
22 Who to screen? Note: The USPSTF actually recommends screening up to age 80 but the ACCP guidelines (and Medicare reimbursement) only go up to age 77 as that was the cutoff in the NLST
23 Who not to screen? Because of the tenuous balance of benefit and harms, routinely screening other patients based on risk calculators or other estimates of high risk is not recommended Shared decision-making is also universally recommended before formal referral for screening
24 Shared decision making Numerous studies have shown that patients drastically over-estimate the benefit and under-estimate the risk of harm from cancer screening
25 Shared decision making If you are fortunate enough to be part of a healthcare system with a comprehensive program there will be coordinators to handle a lot of the pre-screening education and counseling
26 Benefits of screening Lower chance of dying from lung cancer Not a lower risk of getting lung cancer
27 Harms of screening Radiation exposure False positive results Overdiagnosis Smoking cessation
28 Harms of screening Radiation exposure Risk depends on a number of factors including baseline cancer risk Higher in women (breast cancer) USPSTF guideline cites an estimated 4/10,000 people that would die from cancer related to the excess radiation from screening J Med Screen 2008; 15(3):
29 Harms of screening False positive results: 96% of abnormal findings in the NLST were false positives Extra scans Unnecessary invasive procedures
30 Harms of screening Overdiagnosis No hard data but it has been estimated that ~10% of cancers found by screening would not have been detected otherwise (patient would have died with it, not from it) Ann Intern Med. 2014;160:
31 Smoking cessation All patients who smoke and are referred for screening should also have smoking cessation counseling In one VA study, while virtually all PCP s assessed smoking histories, only 23% referred active smokers for smoking cessation services Ann Am Thoracic Soc 2016 Nov;13(11):
32 Smoking cessation Unfortunately, another VA study demonstrated that half (49%) of the patients seemed to be less motivated to stop smoking after enrolling in screening JAMA Intern Med. 2015;175(9):
33 When to stop screening When a patient no longer meets criteria: greater than 80 years of age or 15 years of abstinence from smoking Patient is no longer healthy enough to benefit from screening
34 Who not to screen? Routinely screening patients (especially younger ones) that do not fall into the listed criteria but are deemed high risk is not recommended
35 Who not to screen? USPSTF estimates that if you started screening before the age of 40 it would be mathematically impossible to justify the radiation exposure (would need a 125% reduction in mortality) J Med Screen 2008; 15(3):
36 Who not to screen? Arguably the most frequent cause of inappropriate screening, however, is to refer patients who would not benefit from early detection
37 Who not to screen? Typically these would be patients who: Have a limited life expectancy due to other end stage disease(s) Are not candidates for curative surgery (98% of stage I patients in NLST underwent surgery) Would not tolerate chemo/radiation due to poor functional status
38 Components of a good screening program Having a high quality screening program is essential to achieve the maximum patient benefit The cost/benefit ratio, in particular, can change substantially with relatively small changes in implementation N Engl J Med 2014;371:
39 Components of a good screening program Has mechanisms in place to ensure patients meet appropriate criteria and are counseled prior to screening as already discussed (shared decision making, smoking cessation, etc)
40 Components of a good screening program Multidisciplinary involvement by radiologists, pulmonologists, thoracic surgeons, and oncologists with algorithms in place to guide management of any positive findings (including the avoidance of overtreatment and unnecessary invasive procedures)
41 Components of a good screening program Scans should be read by experienced thoracic radiologists with standardized definitions of what constitutes a positive test and report the results in a structured format (e.g., LungRADS)
42 LungRADS Similar to Bi-RADS used for mammography Allows for standardization and reporting of findings into a database for further study (also recommended by the guidelines)
43
44 Components of a good screening program Strategies should be in place to ensure compliance with follow up (both annual and any short-interval scans that may be needed)
45 Other challenges Outside of a research setting it may be difficult to achieve the same results Worth noting that the surgical mortality in the NLST was only 1%, much lower than the national average
46 Other challenges The sheer volume of patients who qualify preclude many health systems from creating centralized screening programs
47 Other challenges The VA has estimated that there are approximately 900,000 eligible veterans and a feasibility study suggested it will be very difficult to administer a comprehensive program with the available resources
48 Incidentalomas Most abnormal findings will not be lung nodules Many will be new/incidental and may require follow up (detailed guidelines are in process)
49 Billing/Coding Lack of time is the most commonly cited reason for not counseling patients prior to screening Can t do much about time but medicare does cover a visit for LDCT counseling and shared decision making Chest 2017; 152(1):
50 Billing/Coding G0296 Counseling visit to discuss need for lung cancer screening (LDCT) using low dose CT scan (service is for eligibility determination and shared decision making) Need to document the eligibility criteria and the LDCT order Chest 2017; 152(1):
51 Billing/Coding G0297 Low dose CT scan (LDCT) for lung cancer screening ICD-10 Codes Z Chest 2017; 152(1):
52 Take home points LDCT screening for lung cancer carries a favorable but tenuous balance of benefit and harms. (ACCP) Appropriate patient selection and counseling are crucial (smoking cessation!)
53 Take home points Referral to an experienced program is also recommended in order to realize the full benefit while minimizing harms
54 Questions? My thanks to the FSACOFP for inviting me to speak and to you for listening
What to know and what to make of it
Lung Cancer Screening: What to know and what to make of it J. Matthew Reinersman, MD Assistant Professor of Surgery Division of Thoracic and Cardiovascular Surgery Department of Surgery University of Oklahoma
More informationLung Cancer Screening: To screen or not to screen?
Lung Cancer Screening: To screen or not to screen? Dan J. Raz, M.D. Co Director, Lung Cancer Screening Program Co Director, LungCancer and Thoracic OncologyProgram Assistant Professor, Thoracic Surgery
More informationVHA Demonstration Project for Lung Cancer Screening Using Low-Dose Chest CT Screening
VHA Demonstration Project for Lung Cancer Screening Using Low-Dose Chest CT Screening ATS San Francisco 2016 James K. Brown MD 1, Kathryn L. Rice, MD 2 (1) San Francisco VA (2) Minneapolis VAMC Disclosures
More informationLung Cancer Screening: Benefits and limitations to its Implementation
Lung Cancer Screening: Benefits and limitations to its Implementation Rolando Sanchez, MD Clinical Assistant Professor Pulmonary-Critical Care Medicine University of Iowa Lung cancer - Epidemiology Cancer
More informationDisclosures. Overview. Selection the most accurate statement: Updates in Lung Cancer Screening 5/26/17. No Financial Disclosures
Updates in Lung Cancer Screening Disclosures No Financial Disclosures Neil Trivedi, MD Associate Professor of Clinical Medicine SF VAMC Pulmonary and Critical Care Director, Bronchoscopy & Interventional
More informationLung Cancer Screening
Lung Cancer Screening Preston Wright, DO University of Kansas School of Medicine- Wichita Family Medicine Residency at Via Christi Hospitals 1 Objectives Identify patients who need screened for lung cancer
More informationLung Cancer Screening: Current Status
Lung Cancer Screening: Current Status I have no financial relationships, arrangements or affiliations and this presentation will not include discussion of investigational or off-label use of a product
More informationLung Cancer Screening:
Lung Cancer Screening: Maximizing Gain and Dealing with Pandora s Box Mark M. Fuster, MD Division of Pulmonary & Critical Care UCSD Department of Medicine & VA San Diego Healthcare Service San Diego, CA
More informationLung Cancer Screening
Scan for mobile link. Lung Cancer Screening What is lung cancer screening? Screening examinations are tests performed to find disease before symptoms begin. The goal of screening is to detect disease at
More informationLUNG CANCER SCREENING: LUNG CANCER SCREENING: THE TIME HAS COME LUNG CANCER: A NATIONAL EPIDEMIC
: THE TIME HAS COME Physician Leader, Lung Cancer Multi-Disciplinary Program Fletcher Allen Health Care Annual Meeting Montpelier, VT - April 25, 2014 Gerald S. Davis, MD Professor of Medicine University
More informationLung Cancer Screening
Scan for mobile link. Lung Cancer Screening What is lung cancer screening? Screening examinations are tests performed to find disease before symptoms begin. The goal of screening is to detect disease at
More informationExample of lung screening
Justification of the use of CT for individual health assessment of asymptomatic people How to obtain evidence for IHA - Example of lung screening Mathias Prokop, MD PhD Professor of Radiology Radboud University
More informationCT Lung Screening Implementation Challenges: State Based Initiatives
CT Lung Screening Implementation Challenges: State Based Initiatives Andrea McKee, MD Chair Radiation Oncology Lahey Hospital and Medical Center Co-Director Rescue Lung, Rescue Life Program Co-Chair Massachusetts
More informationSHARED DECISION MAKING AND LUNG CANCER SCREENING
SHARED DECISION MAKING AND LUNG CANCER SCREENING DISCLOSURES Cathleen E. Morrow, MD None William C. Black, MD No financial disclosure Co-investigator for NLST Member of the ACR Lung-RADS Screening Registry
More informationCancer Screenings and Early Diagnostics
Cancer Screenings and Early Diagnostics Ankur R. Parikh, D.O. Medical Director, Center for Advanced Individual Medicine Hematologist/Medical Oncologist Atlantic Regional Osteopathic Convention April 6
More informationLUNG CANCER: LDCT DISCLOSURES NONE. Erika Swanson, MD Radiation Oncologist Ascension Columbia-St. Mary s February 1, /9/2018
LUNG CANCER: LDCT Erika Swanson, MD Radiation Oncologist Ascension Columbia-St. Mary s February 1, 2018 DISCLOSURES 2 NONE 1 OBJECTIVES 3 Rationale and evidence for LDCT for lung cancer screening Review
More informationRichard M. Hoffman, MD, MPH University of Iowa Carver College of Medicine Holden Comprehensive Cancer Center
Richard M. Hoffman, MD, MPH University of Iowa Carver College of Medicine Holden Comprehensive Cancer Center Consultant, Healthwise, developing cancer screening decision support tools Consultant, Agency
More informationCT Lung Screening Implementation Challenges: ALA/ATS Implementation Microsite
CT Lung Screening Implementation Challenges: ALA/ATS Implementation Microsite Andrea McKee, MD Chair Radiation Oncology Lahey Hospital and Medical Center November 2018 2016 data, 3 years after ACS recommendation
More informationScreening Programs background and clinical implementation. Denise R. Aberle, MD Professor of Radiology and Engineering
Screening Programs background and clinical implementation Denise R. Aberle, MD Professor of Radiology and Engineering disclosures I have no disclosures. I have no conflicts of interest relevant to this
More informationLung Cancer Screening In High Risk Populations:
Lung Cancer Screening In High Risk Populations: Michael Jaklitsch, M.D. Co-Chair of AATS Task Force on Lung Cancer Screening and Surveillance From the Brigham and Women s Hospital Harvard Medical School.
More informationPage 1. Cancer Screening for Women I have no conflicts of interest. Overview. Breast, Colon, and Lung Cancer. Jeffrey A.
Cancer Screening for Women 2017 Breast, Colon, and Lung Cancer Jeffrey A. Tice, MD Professor of Medicine Division of General Internal Medicine University of California, San Francisco I have no conflicts
More informationLung cancer screening in Switzerland
SAMO Interdisciplinary Workshop on Chest Tumors 27 th and 28 th January 2017 Hotel Hermitage, Lucerne Lung cancer screening in Switzerland Walter Weder, MD, Professor of Surgery University Hospital Zurich,
More informationLung Cancer Screening Benefits, Risks & Challenges
Lung Cancer Screening Benefits, Risks & Challenges Polly Sather, APRN Yale Lung Screening and Nodule Program (Yale Lung SCAN) A Multidisciplinary Comprehensive Initiative Yale Cancer Center Thoracic Oncology
More informationLUNG CANCER SCREENING
LUNG CANCER SCREENING Christopher Lettieri MD, FACP, FCCP, FAASM Pulmonary/Critical Care Consultant to the Surgeon General Professor of Medicine Walter Reed National Military Medical Center American College
More informationSelected Controversies. Cancer Screening. Breast Cancer Screening. Selected Controversies. Page 1. Using Best Evidence to Guide Practice
Cancer Screening Using Best Evidence to Guide Practice Judith M.E. Walsh, MD, MH Division of General Internal Medicine Women s Health Center of Excellence University of California, San Francisco Selected
More informationA Summary from the 2013World Conference on Lung Cancer Sydney, Australia
A Summary from the 2013World Conference on Lung Cancer Sydney, Australia In 2011, the U.S. National Lung Screening Trial (NLST) has demonstrated that low-dose computed tomography (LDCT) screening of high
More informationScreening for Lung Cancer - State of the Art
Screening for Lung Cancer - State of the Art Rohit Kumar, MD Assistant Professor of Medicine Fox Chase Cancer Center Temple University School of Medicine Philadelphia, PA Objectives Review current evidence
More informationChristine Argento, MD Interventional Pulmonology Emory University
Christine Argento, MD Interventional Pulmonology Emory University Outline Lung Cancer Statistics Prior Studies for Lung Cancer Screening NLST Studies Following NLST Future Directions Lung Cancer American
More informationAn Update on Lung Cancer Screening Policy and the Role of Quitlines
An Update on Lung Cancer Screening Policy and the Role of Quitlines Robert J. Volk, PhD Vance Rabius, PhD The University of Texas MD Anderson Cancer Center North American Quitline Consortium NAQC Conference
More informationGoals of Presentation
Goals of Presentation Review context of lung cancer screening why is it important? Review data from NLST supporting screening with lowdose CT (LDCT) scanning Discuss the pros and cons of LDCT screening
More informationSHARED DECISION MAKING IN MEDICARE COVERAGE
SHARED DECISION MAKING IN MEDICARE COVERAGE Kate Goodrich, MD MHS Director, Center for Clinical Standards and Quality CMS April 2, 2016 Disclaimer: Views and comments in this presentation are those of
More informationLDCT Screening. Steven Kirtland, MD. Virginia Mason Medical Center February 27, 2015
LDCT Screening Steven Kirtland, MD Virginia Mason Medical Center February 27, 2015 2 Disclosures 4 5 Cancer Screening Mrs H 64yo 50 pk year smoker Lung Cancer Epidemiology Leading Cause of Cancer Death
More informationVeterans Health Administration Lung Cancer Screening Demonstration Project: Results & Lessons Learned
Veterans Health Administration Lung Cancer Screening Demonstration Project: Results & Lessons Learned Jane Kim, MD, MPH Acting Chief Consultant for Preventive Medicine National Center for Health Promotion
More informationThe National Lung Screening Trial (NLST)
The National Lung Screening Trial (NLST) Pamela Marcus US National Cancer Institute May 21, 2012 Today s talk NLST: an overview Typical challenges in cancer screening RCTs Starting ti a trial in the presence
More informationCT screening for lung cancer. Should it be done in the Indian context?
CT screening for lung cancer Should it be done in the Indian context? Wilson and Jungner screening criteria 1. The condition sought should be an important health problem. 2. There should be an accepted
More informationPulmonologist s Perspective
Low-dose CT for lung cancer screening Pulmonologist s Perspective Literature Review Kang-Yun Lee, MD PhD Department of Thoracic Medicine Taipei Medical University- Shuang Ho Hospital Taiwan Local vs. Advanced
More informationA Comprehensive Cancer Center Designated by the National Cancer Institute
N C I C C C A Comprehensive Cancer Center Designated by the National Cancer Institute Screening and Early Detection of Lung Cancer: Ready for Practice? David S. Ettinger, MD, FACP, FCCP Alex Grass Professor
More informationNone
2014 None rosemary clooney Cancer is one of the most common diseases in the developed world: 1 in 4 deaths are due to cancer 1 in 17 deaths are due to lung cancer Lung cancer is the most common
More informationFaculty Disclosure. Objectives. Lung Cancer in Kentucky: Improving Patient Outcomes 10/28/16. Lung Cancer Burden in Kentucky
Lung Cancer in Kentucky: Improving Patient Outcomes Faculty Disclosure The presenter and members of the development team do not have any conflicts to report. Celeste T. Worth, MCHES Kentucky Collaborative
More informationThe status of Lung Cancer Screening Guidelines. Peter B. Bach, MD, MAPP Memorial Sloan Kettering Cancer Center
The status of Lung Cancer Screening Guidelines Peter B. Bach, MD, MAPP Memorial Sloan Kettering Cancer Center bachp@mskcc.org @peterbachmd Homogeneity of guidelines But what about these? Outside the box
More informationCurrent Approach to Screening for Lung Cancer. James R Jett M.D.
Current Approach to Screening for Lung Cancer James R Jett M.D. Potential Conflicts of Interest I am Chief Medical Officer for Oncimmune Ltd (Biomarkers of Cancer) Co-Editor of Lung Cancer Section of UP-TO-DATE
More informationPatient Decision Aid. Summary Guide for Clinicians. Clinician s Checklist
U.S. Department of Health & Human Services About Us Careers Contact Us Español FAQ Email Updates Effective Health Care Home / Decision Aids / Lung Cancer Screening Tools Patient Decision Aid Summary Guide
More informationAnn Intern Med. 2012;156(5):
Lung Cancer Screening Update Doug Arenberg, M.D. University of Michigan Outline Screening; Some simple but necessary truths Do people benefit from screening? What are the harms (and are they outweighed
More informationSCBT-MR 2016 Lung Cancer Screening in Practice: State of the Art
SCBT-MR 2016 Lung Cancer Screening in Practice: State of the Art Reginald F. Munden MD, DMD, MBA I have no conflicts of interest to report National Lung Cancer Screening Trial 20% lung cancer mortality
More informationLung Cancer Screening. Ashish Maskey MD Interventional Pulmonology UK Health Care Dec 1 st 2017
Lung Cancer Screening Ashish Maskey MD Interventional Pulmonology UK Health Care Dec 1 st 2017 Nearly one in six American adults currently smoke cigarettes An estimated 40 million adults in the United
More informationCopyright Archana Nandakumar
Copyright 2016 Archana Nandakumar Systems Modeling of Lung Cancer Screening Programs to Improve Quality Archana Nandakumar A thesis submitted in partial fulfillment of the requirements for the degree of
More informationPANEL DISCUSSION: SCREENING FOR LUNG CANCER. Anthony D Weaver MD
PANEL DISCUSSION: SCREENING FOR LUNG CANCER Anthony D Weaver MD Disclosures Anthony Weaver has no relationships to disclose. Thank God! A panel of experts! An Equal Opportunity University Objectives 1.
More informationRole of CT in Lung Cancer Screening: 2010 Stuart S. Sagel, M.D.
Role of CT in Lung Cancer Screening: 2010 Stuart S. Sagel, M.D. Lung Cancer 219,440 new cases/year in U.S. (2009) 169,390 deaths/year in U.S. mortality greater than from breast, colon, prostate CA combined
More informationObjectives. Why? Why? Background 11/5/ % incurable disease at presentation Locally advanced disease Metastasis. 14% 5 year survival
Objectives Appraise lung cancer screening trials results Review screening guidelines Lung Cancer Screening: Past, Present and Future Chi Wan Koo, MD Koo.chiwan@mayo.edu Discuss recommendations essential
More informationPage 1. Controversies in Cancer Prevention and Screening. Disclosures. Screening. Principles of Screening. I have no conflicts of interest
Controversies in Cancer Prevention and Screening Disclosures Using the Best Evidence in 2015 I have no conflicts of interest Judith M.E. Walsh, MD, MPH Division of General Internal Medicine Women s Health
More informationDISCLOSURE. Lung Cancer Screening: The End of the Beginning. Learning Objectives. Relevant Financial Relationship(s) Off Label Usage
Peninsula Regional Medical Center 12 th Annual Lung Cancer Conference March 9, 2017 Lung Cancer Screening: The End of the Beginning David E. Midthun M.D. Professor of Medicine College of Medicine, Mayo
More informationCT Low Dose Lung Cancer Screening. Part I. Journey to LDCT LCS Program
CT Low Dose Lung Cancer Screening Part I Journey to LDCT LCS Program Paul Johnson, M.S., DABHP, DABR Cleveland Clinic September 26, 2015 Lung Caner is No. 1 In Cancer Related Death In The United States
More informationLung Cancer Screening: To Screen or Not to Screen?
Lung Cancer Screening: To Screen or Not to Screen? Lorriana Leard, MD Co-Director of UCSF Lung Cancer Screening Program Vice Chief of Clinical Activities UCSF Pulmonary, Critical Care, Allergy & Sleep
More information10/17/16. Lung Cancer Screening. Question 1: Does lung cancer screening make sense? 3rd lung cancer third most prevalent tumor type
Lung Cancer Screening Greg Rogalski Mercy Radiology Group greg@grogo.org Question 1: Does lung cancer screening make sense? 2 Requirements for successful screening process Sufficiently high prevalence
More informationMEDICAL POLICY SUBJECT: LOW-DOSE COMPUTED TOMOGRAPHY (LDCT) FOR LUNG CANCER SCREENING. POLICY NUMBER: CATEGORY: Technology Assessment
MEDICAL POLICY SUBJECT: LOW-DOSE COMPUTED CANCER SCREENING 05/18/05, 03/16/06, 12/21/06, 08/16/07, PAGE: 1 OF: 6 If a product excludes coverage for a service, it is not covered, and medical policy criteria
More informationDOH LUNG CANCER SCREENING SERVICE SPECIFICATIONS
DOH LUNG CANCER SCREENING SERVICE SPECIFICATIONS December 2018 Page 1 of 18 Document Title: Document Ref. Number: DOH Lung Cancer Screening Service Specifications PH/NCD/LCSC/SR/0.9 Version: 0.9 Approval
More informationLung Cancer Screening
Lung Cancer Screening Steven Leh, MD, FCCP Diplomat of the American Association for Bronchology and Interventional Pulmonology Aurora Medical Group Pulmonary and Sleep Medicine February 10, 2018 Disclosures
More informationThe complex, intertwined role of patients in research and care
Session 3: The complex, intertwined role of patients in research and care Joseph Chin, MD, MS, Acting Deputy Director, Coverage and Analysis Group, Centers for Medicare & Medicaid Services The complex,
More informationRe: USPSTF Draft Research Plan for Lung Cancer Screening
May 30, 2018 USPSTF Center for Evidence and Practice Improvement Agency for Healthcare Research and Quality 5600 Fishers Lane Mailstop 06E53A Rockville, Maryland 20857 Electronic Submission: Online Comments
More informationLUNG CANCER SCREENING: ON WHOM DID YOU DO IT AND ON WHOM DO YOU RESPOND TO THE RESULTS?
LUNG CANCER SCREENING: ON WHOM DID YOU DO IT AND ON WHOM DO YOU RESPOND TO THE RESULTS? DAVID O. WILSON, MD, MHP DIRECTOR GEORGIA COOPER MEMORIAL LUNG CANCER RESEARCH REGISTRY UNIVERSITY OF PITTSBURGH
More informationLung Cancer Screening Trials. Edward Harris Respiratory Research Fellow Sir Charles Gairdner Hospital
Lung Cancer Screening Trials Edward Harris Respiratory Research Fellow Sir Charles Gairdner Hospital Lung Cancer Screening in Australia Not Funded except as part of a clinical trial Rationale PLCO, ELCAP
More informationSCREENING FOR EARLY LUNG CANCER. Pang Yong Kek
SCREENING FOR EARLY LUNG CANCER Pang Yong Kek Lecture Outline Why performing screening? How to improve early detection? Benefits and Risks of screening Challenges in screening Conclusion Why Performing
More informationLearning Objectives. 1. Identify which patients meet criteria for annual lung cancer screening
Disclosure I, Taylor Rowlett, DO NOT have a financial interest /arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context
More informationLung Cancer Screening: Who, What, Why? Myths Dispelled
Lung Cancer Screening: Who, What, Why? Myths Dispelled Presented By: MaryAnn Tateosian, RT (R), M, MM, CIIP MGH Lung Screening Program Manager December 11, 2018 1 Lung Screening Objectives History of Smoking
More informationCriteria USPSTF CMS. Frequency Annual screening Annual screening. No signs or symptoms of lung cancer
Lung Cancer Screening Guidelines with low- dose computed tomography (LDCT): USPSTF and CMS February 6, 2015 Kentucky Cancer Consortium and Kentucky LEADS Component 3 Jennifer Redmond Knight, DrPH, jredknight@kycancerc.org
More informationGuidelines in Breast Screening Mammography: Pros and Cons JOSLYN ALBRIGHT, MD SURGICAL ONCOLOGIST, ADVOCATE CHRIST MEDICAL CENTER OCTOBER 1, 2016
Guidelines in Breast Screening Mammography: Pros and Cons JOSLYN ALBRIGHT, MD SURGICAL ONCOLOGIST, ADVOCATE CHRIST MEDICAL CENTER OCTOBER 1, 2016 FACT Breast Cancer Screening Saves Lives Since 1990, screening
More informationPage 1. Selected Controversies. Cancer Screening! Selected Controversies. Breast Cancer Screening. ! Using Best Evidence to Guide Practice!
Cancer Screening!! Using Best Evidence to Guide Practice! Judith M.E. Walsh, MD, MPH! Division of General Internal Medicine! Womenʼs Health Center of Excellence University of California, San Francisco!
More informationThe Challenge of Cancer Screening Part One Prostate Cancer and Lung Cancer Screening
The Challenge of Cancer Screening Part One Prostate Cancer and Lung Cancer Screening The Challenge of Cancer Screening Part One Prostate Cancer and Lung Cancer Screening By Marsha Fountain, RN, MSN The
More informationCharles Mulligan, MD, FACS, FCCP 26 March 2015
Charles Mulligan, MD, FACS, FCCP 26 March 2015 Review lung cancer statistics Review the risk factors Discuss presentation and staging Discuss treatment options and outcomes Discuss the status of screening
More informationLung Cancer Screening: Evidence and current recommendations
Lung Cancer Screening: Evidence and current recommendations 20 th March 2018 Dr Annette McWilliams Fiona Stanley Hospital University of Western Australia WA Cancer & Palliative Care Network I have no financial
More informationSTRENGTHENING ADHERENCE IN LUNG CANCER SCREENING
STRENGTHENING ADHERENCE IN LUNG CANCER SCREENING Lung Cancer Alliance www.lungcanceralliance.org 1-800-298-2436 1700 K Street NW, Suite 660 Washington, D.C. 20006 TABLE OF CONTENTS Introduction... 2 Adherence
More informationLung Cancer Screening
Lung Cancer Screening v Lung Cancer: America s leading cancer killer Annual US cancer mortality 158,040 221,000 new diagnoses in US 4,100 14,180 27,540 Lung 40,560 40,730 49,700 Cervix Ovary Prostate Pancreas
More informationLUNG CANCER SCREENING WHAT S THE IMPACT? Nitra Piyavisetpat, MD Department of Radiology Chulalongkorn University
LUNG CANCER SCREENING WHAT S THE IMPACT? Nitra Piyavisetpat, MD Department of Radiology Chulalongkorn University Objective LDCT lung cancer screening (LCS) Potential Benefits & Harms Recommendation of
More informationEquity Issues with Lung Cancer Screening Prevent Cancer - Quantitative Imaging Workshop November 5-6, 2018 Alexandria, VA
Equity Issues with Lung Cancer Screening Prevent Cancer - Quantitative Imaging Workshop November 5-6, 2018 Alexandria, VA Mary Pasquinelli, MS, APRN, FNP-BC Pulmonary and Thoracic Medical Oncology Director,
More informationLung Cancer screening :
Lung Cancer screening : Pro-Contra SAMO interdisciplinary workshop on chest tumors 27 and 28 january 2017 Prof L.P.Nicod Sevice de pneumologie CHUV-Lausanne -CH Lung Cancer How big is the problem? Epidemiology
More informationIntroduction and Background
CT Lung Cancer Screening and the Medical Physicist: Background, Findings and Participant Dosimetry Summary of the National Lung Screening Trial (NLST) Randell Kruger, PhD, DABR Medical Physics Section
More informationScreening for Lung Cancer: New Guidelines, Old Problems
Screening for Lung Cancer: New Guidelines, Old Problems Robert Schilz DO, PhD Associate Professor of Medicine Interim Chief of the Division of Pulmonary, Critical Care and Sleep Medicine University Hospitals
More informationLung Cancer Screening Computed Tomography Screening in Pa6ents at Risk for Lung Cancer
Lung Cancer Screening Computed Tomography Screening in Pa6ents at Risk for Lung Cancer Doug Arenberg, M.D. University of Michigan Disclosures Objec6ve Define patients who will benefit from screening for
More informationUpdates In Cancer Screening: Navigating a Changing Landscape
Updates In Cancer Screening: Navigating a Changing Landscape Niharika Dixit, MD I have no conflict of interest. 1 Why Should You Care Trends in Cancer Incidence by Site United States. Siegal Et al: CA
More informationShared decision-making conversations and smoking cessation interventions: critical components of low-dose CT lung cancer screening programs
Review Article Shared decision-making conversations and smoking cessation interventions: critical components of low-dose CT lung cancer screening programs Lisa M. Lowenstein 1, Gary M. R. Deyter 1, Shawn
More informationLung Cancer Screening
Lung Cancer Screening Mission Health Poised to Usher in New Era of Hope for Lung Cancer Patients Everyone in western North Carolina deserves the best care possible the patient at high risk for lung cancer,
More informationPolicy Brief: Screening for Lung Cancer Using Low Dose Computed Tomography
Policy Brief: Screening for Lung Cancer Using Low Dose Computed Tomography The California Technology Assessment Forum (CTAF) reviewed this topic according to their established criteria for safety, efficacy
More informationHarnessing the Power of the DNP: Leading the Development and Implementation of an Evidence Based Clinical Program JOELLE FATHI, DNP, RN, ARNP, CTTS
Harnessing the Power of the DNP: Leading the Development and Implementation of an Evidence Based Clinical Program JOELLE FATHI, DNP, RN, ARNP, CTTS Objectives Identify innovative ways in which the DNP
More informationEvidence-based Diagnosis: A Workshop on Evaluating and Using Medical Tests Small Group 4: Friday, June 10, 3:00 4:30. Problems Without Answers
Evidence-based Diagnosis: A Workshop on Evaluating and Using Medical Tests Small Group 4: Friday, June 10, 3:00 4:30 Problems Without Answers A B C D E F G H Objectives: Volunteer Bias Lead Time Bias Differing
More informationLung Cancer Screening: A review of the recommendations Friday, November 11th, 2016 from 11:45 to 12:15. Dr. Tunji Fatoye Dr.
Lung Cancer Screening: A review of the recommendations Friday, November 11th, 2016 from 11:45 to 12:15 Dr. Tunji Fatoye Dr. Alan Kaplan Conflict of Interest Disclosure: Speaker Name: Alan Kaplan FINANCIAL
More informationNew Advances in Lung Cancer
New Advances in Lung Cancer Douglas E. Wood, MD, FACS, FRCSEd (ad hom) Professor and Chief Division of Cardiothoracic Surgery Vice-Chair, Department of Surgery Endowed Chair in Lung Cancer Research University
More informationAuthor(s) : Title: HERCA WG Medical Applications / Sub WG Exposure of Asymptomatic Individuals in Health Care
Author(s) : Juergen Griebel, (Bfs, DE) Steve Ebdon-Jackson (HPA, UK) Title: HERCA WG Medical Applications / Sub WG Exposure of Asymptomatic Individuals in Health Care Position Paper on Screening Summary:
More informationThe Maine Lung Cancer Coalition. Working Together to Reduce Lung Cancer in Maine
The Maine Lung Cancer Coalition Working Together to Reduce Lung Cancer in Maine funding Maine Lung Cancer Coalition (MLCC) Webinar Lung Cancer Screening: Following Up On Abnormal Low Dose CT Scans with
More informationCT Screening for Lung Cancer for High Risk Patients
CT Screening for Lung Cancer for High Risk Patients The recently published National Lung Cancer Screening Trial (NLST) showed that low-dose CT screening for lung cancer reduces mortality in high-risk patients
More informationRobert J. McKenna M.D. Chief, Thoracic Surgery Cedars Sinai Medical Center
You Smoke, You Get Lung Cancer, You Die: Can Screening Change this Paradigm? Robert J. McKenna M.D. Chief, Thoracic Surgery Cedars Sinai Medical Center AATS Saturday 4/28/2012 Cancer Screening Cancer
More informationLUNGS? YOU GET THESE YOUR GUIDE TO YEARLY LUNG CANCER SCREENING CHECKED REGULARLY. WHAT ABOUT YOUR. Think. Screen. Know.
YOU GET THESE CHECKED REGULARLY. WHAT ABOUT YOUR LUNGS? YOUR GUIDE TO YEARLY LUNG CANCER SCREENING WHAT YOU SHOULD KNOW BEFORE, DURING, AND AFTER Think. Screen. Know. Talk to your doctor. TABLE OF CONTENTS
More informationRE: Coverage of low-dose Computed Tomography (LDCT) lung cancer screening in Independent Diagnostic Testing Facilities (IDTFs)
May 11, 2018 Tamara Syrek Jensen, JD Director, Coverage and Analysis Group Department of Health and Human Services Center for Medicare and Medicaid Services 7500 Security Boulevard, Mail Stop S3-02-01
More informationLow-Dose CT Lung Screening
Community Outreach: Outcomes Report 2018 Low-Dose CT Lung Screening Significance & Background: Lung cancer is our number one cancer site in our Region, based on data from our Cancer Data Services Department.
More information2015 Annual Report Lung Screening
05 Annual Report Lung Screening Flaget Cancer Center Monte Martin, MD Joseph Shaughnessy, MD CANCER SERVICES PROGRAM From the Director We are pleased to share with you the Lung Cancer Report for 05. With
More informationAmerican Medical Association Journal of Ethics
American Medical Association Journal of Ethics July 2015, Volume 17, Number 7: 601-607 ETHICS CASE Close-Call Screening and Shared Decision Making Commentary by Evelyn Chan, MD, MS Dr. Samuelson is an
More information2018 Community Outreach Report
4.1 Prevention Program Lung Cancer Prevention 2018 Community Outreach Report The focus on prevention of lung cancer was chosen by the Cancer Committee because lung cancer is the leading cause of death
More informationRecommendations on Screening for Lung Cancer 2016
Recommendations on Screening for Lung Cancer 2016 Canadian Task Force on Preventive Health Care (CTFPHC) Putting Prevention into Practice Canadian Task Force on Preventive Health Care Groupe d étude canadien
More informationSHARED DECISION MAKING WORKSHOP SMALL GROUP ACTIVITY LUNG CANCER SCREENING ROLE PLAY
SHARED DECISION MAKING WORKSHOP LUNG CANCER SCREENING ROLE PLAY Instructions Your group will role play a Shared Decision Making (SDM) conversation around lung cancer screening using the provided scenario.
More informationScreening for Breast Cancer
Understanding Task Force Recommendations Screening for Breast Cancer U.S. Preventive Services Task Force (Task Force) has issued a final recommendation statement on Screening for Breast Cancer. se final
More informationLessons learned for the conduct of a successful screening trial
Lessons learned for the conduct of a successful screening trial Christine D. Berg, M.D. Adjunct Professor Department of Radiation Oncology Johns Hopkins Medicine IOM State of the Science in Ovarian Cancer
More information